GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain ...

RockBridge Treatment and Recovery aims to change the withdrawal experience, turning a negative situation into one of ...

Indianapolis-based Lilly is testing its weight loss drug Zepbound to treat addiction, while Meta outages affected more than ...

Knoxville-Knox County Planning voted in-favor of rezoning an area off Clinton Highway, making way for a new drug and alcohol ...

Originally approved for medical use in the U.S. in 1984 to treat heroin addiction and available to treat AUD since 1994, the drug binds to opioid receptors, part of the body’s system for ...

Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster ...

Knoxville-Knox County Planning Commission voted in favor of rezoning an area off Clinton Highway to make way for a new drug ...

Alcohol abuse is among the leading cause of preventable death in the United States—more than opioids such as fentanyl.

Brainsway ( (BWAY) ) has provided an announcement.

Brightview Health Youngstown Addiction Treatment Center has been a beacon of hope for more than 900 people, including Pastor ...